2022
DOI: 10.1016/j.poly.2021.115561
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, crystallographic structure, theoretical studies, and in vitro cytotoxicity assessment of two Gd(III) and Ce(IV) complexes containing pyridine-2,6-dicarboxylate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…Thus, the complex of 8-hydroxyquinolone derivative [CeL 4 ] is effective against human ovarian (SK-OV-3), liver (BEL-744), and lung (NCl-H460) cancer cells, with good selectivity compared to a normal liver cell line (HL-7702) [ 55 ]. The Ce(IV) complex of 3-MBTMPD imine derivative [CeL(NO 3 ) 2 (H 2 O) 2 ] possesses significant cytotoxicity in cervical (HeLa) and breast (MCF-7) cancer cells [ 56 ], while the Ce(IV)-bearing dicarboxylate [CeL 3 ] 2− shows activity against breast cancer (MCF-7), colon adenocarcinoma (HT-29) and lymphocyte (HT-60) cells [ 57 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the complex of 8-hydroxyquinolone derivative [CeL 4 ] is effective against human ovarian (SK-OV-3), liver (BEL-744), and lung (NCl-H460) cancer cells, with good selectivity compared to a normal liver cell line (HL-7702) [ 55 ]. The Ce(IV) complex of 3-MBTMPD imine derivative [CeL(NO 3 ) 2 (H 2 O) 2 ] possesses significant cytotoxicity in cervical (HeLa) and breast (MCF-7) cancer cells [ 56 ], while the Ce(IV)-bearing dicarboxylate [CeL 3 ] 2− shows activity against breast cancer (MCF-7), colon adenocarcinoma (HT-29) and lymphocyte (HT-60) cells [ 57 ].…”
Section: Introductionmentioning
confidence: 99%